Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis

Sanaa Ben Djemaa; Stéphanie David; Katel Hervé-Aubert; Annarita Falanga; Stefania Galdiero; Émilie Allard-Vannier; Igor Chourpa; Emilie Munnier

Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis

Sanaa Ben Djemaa ¹ Stéphanie David ^{1, *} Katel Hervé-Aubert ¹ Annarita Falanga ² Stefania Galdiero ³ Émilie Allard-Vannier ¹ Igor Chourpa ¹ Emilie Munnier ¹

* Corresponding author

1 NMNS - Nanomédicaments et Nanosondes, EA 6295

2 Department of Pharmacy and CIRPeB

3 Department of Pharmacy and CIRPeB

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Biochemistry, Molecular Biology

Life Sciences [q-bio] / Cancer

Life Sciences [q-bio] / Bioengineering

Complete list of metadatas

https://hal-univ-tours.archives-ouvertes.fr/hal-01919906
Contributor : Martin Soucé <>
Submitted on : Monday, November 12, 2018 - 5:58:36 PM
Last modification on : Monday, February 18, 2019 - 2:02:20 PM

Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis

Identifiers

Collections

Citation

Export

Metrics

33

Contact

Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis

Identifiers

Collections

Citation

Export

Share

Metrics

33

Contact